The Division of Pulmonary and Critical Care Medicine has a long history of excellence in airway biology research—both basic and translational—providing insight into the pathophysiology, genetics and treatment of numerous pulmonary diseases. Our physician-scientists have championed respiratory diseases for decades with groundbreaking studies that have been awarded millions in grants from the National Institutes of Health and the National Heart Lung and Blood Institute.
Through our clinical and research efforts, patients have gained access to emerging treatment options for a variety of conditions, from asthma and chronic obstructive pulmonary diseases (COPD) to diseases affecting intensive care and post-lung transplant patients. Our unique bench-to-bedside approach allows us to fast-forward scientific discoveries – taking them directly from the research phase to our patients. We are simultaneously advancing our understanding of disease while ushering these new prevention recommendations, medications and treatments into clinical practice worldwide.
Pulmonary and Critical Care Medicine Research Areas
Our investigators are improving lung health with studies in the following areas:
Recent and current research studies in the Division of Pulmonary and Critical Care Medicine have focused on:
Chronic Obstructive Pulmonary Disease (COPD)
The National Emphysema Treatment Trial is a multi-center study examining the effectiveness of bilateral lung volume reduction surgery in the treatment of emphysema.
Interstitial Lung Disease
The Interstitial Lung Disease (ILC) Clinic advances the understanding of ILD pathogenesis and identifies novel treatments. The David E. Herlihy patient research registry contains key clinical data from patients with ILD and pulmonary fibrosis.
Pulmonary Vascular Disease
Select patients have the opportunity to participate in investigational clinical trials that study the safety and effectiveness of new treatment approaches for specific diseases. Cancer patients have direct access to the latest research-based treatments and clinical trials through our role in the Dana-Farber/Harvard Cancer Center (DF/HCC), a National Cancer Institute-funded consortium.
Visit our clinical trials page for a list of all lung-related clinical trials open to new participants at Brigham and Women’s Hospital and other Partners HealthCare institutions. Only patients who have provided consent participate in studies.
The annual Lung Center Research Symposium and Poster Session at the Brigham Research Institute (BRI) highlights research activities at BWH and encourages cross-collaborative efforts among clinicians and researchers.
The New England Lung Conference featuring BWH lung experts shares research findings and exciting innovations in respiratory care.
Learn how you can support our pulmonary and critical care research projects.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.